Japan COPD Exacerbation Cognitive study
- Conditions
- COPD (Chronic obstructive pulmonary disease)
- Registration Number
- JPRN-jRCT1080224526
- Lead Sponsor
- GlaxoSmithKline K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 150
Patients having COPD attending the outpatient respiratory specialist sites for their disease will be informed about the study and will be invited to join the trial. To be eligible for inclusion, each subject must fulfil ALL of the following criteria:
1. Male or female of age over 40 years
2. Spirometrically confirmed COPD or ACOS according to diagnostic criteria in GOLD document
3. Smoking history (over 10 pack-years)
4. A treated exacerbation of COPD within 12 months prior to the study visit
5. Willing and able to provide informed consent, and able to participate focus groups or cognitive interviews. (Translation will be provided for illiterate participants to provide informed consent)
All patients meeting ANY of the exclusion criteria will be excluded.
1. Current diagnosis of asthma or clinically relevant bronchiectasis. Note: patients with Asthma COPD Overlap Syndrome (ACOS) ARE eligible
2. Patients with a concurrent significant, uncontrolled, active medical condition or disease state of other organ diseases or systematic diseases, psychiatric condition, cognitive impairment or any other reasons that in the investigators opinion, would place patients at risk or interfere with study evaluation or affect participation in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method other<br>Items (word/phrase) which is used in the communication tool for COPD exacerbations between physicians and patients
- Secondary Outcome Measures
Name Time Method other<br>-